Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Ciudad

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Patient Preference and Adherence|April 17, 2013
Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophreniaTatiana Dilla, Antonio Ciudad, María Alvarez
CNS Neuroscience & Therapeutics|September 20, 2008
Olanzapine orally disintegrating tablet: a review of efficacy and complianceLuis San, Marta Casillas, Antonio Ciudad, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 30, 2008
Measuring schizophrenia remission in clinical practiceJordi Alonso, Antonio Ciudad, Alfonso Casado, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 6, 2003
Safety, effectiveness, and quality of life of olanzapine in first-episode schizophrenia: a naturalistic studyJosé Manuel Montes, Antonio Ciudad, Josep Gascón, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 2, 2007
Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional studyLuis San, Antonio Ciudad, Enrique Alvarez, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|September 15, 2004
Safety and tolerability of olanzapine compared with other antipsychotics in the treatment of elderly patients with schizophrenia: a naturalistic studyAntonio Ciudad, José-Manuel Montes, José-Manuel Olivares, et al.
Neuropsychiatric Disease and Treatment|November 16, 2013
Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analysesAntonio Ciudad, Ernie Anand, Lovisa Berggren, et al.
Journal of Clinical Psychopharmacology|May 17, 2006
A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophreniaEnrique Alvarez, Antonio Ciudad, José Manuel Olivares, et al.
Schizophrenia Research|September 5, 2009
Recovery from schizophrenia: results from a 1-year follow-up observational study of patients in symptomatic remissionJulio Bobes, Antonio Ciudad, Enric Alvarez, et al.
Schizophrenia Research|January 27, 2009
Remission in schizophrenia: results from a 1-year follow-up observational studyAntonio Ciudad, Enric Alvarez, Julio Bobes, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Patient Preference and Adherence|April 17, 2013
Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophreniaTatiana Dilla, Antonio Ciudad, María Alvarez
CNS Neuroscience & Therapeutics|September 20, 2008
Olanzapine orally disintegrating tablet: a review of efficacy and complianceLuis San, Marta Casillas, Antonio Ciudad, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 30, 2008
Measuring schizophrenia remission in clinical practiceJordi Alonso, Antonio Ciudad, Alfonso Casado, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 6, 2003
Safety, effectiveness, and quality of life of olanzapine in first-episode schizophrenia: a naturalistic studyJosé Manuel Montes, Antonio Ciudad, Josep Gascón, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 2, 2007
Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional studyLuis San, Antonio Ciudad, Enrique Alvarez, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|September 15, 2004
Safety and tolerability of olanzapine compared with other antipsychotics in the treatment of elderly patients with schizophrenia: a naturalistic studyAntonio Ciudad, José-Manuel Montes, José-Manuel Olivares, et al.
Neuropsychiatric Disease and Treatment|November 16, 2013
Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analysesAntonio Ciudad, Ernie Anand, Lovisa Berggren, et al.
Journal of Clinical Psychopharmacology|May 17, 2006
A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophreniaEnrique Alvarez, Antonio Ciudad, José Manuel Olivares, et al.
Schizophrenia Research|September 5, 2009
Recovery from schizophrenia: results from a 1-year follow-up observational study of patients in symptomatic remissionJulio Bobes, Antonio Ciudad, Enric Alvarez, et al.
Schizophrenia Research|January 27, 2009
Remission in schizophrenia: results from a 1-year follow-up observational studyAntonio Ciudad, Enric Alvarez, Julio Bobes, et al.
Pageof 4